Raymond James & Associates’s iShares MSCI EAFE Min Vol Factor ETF EFAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$8.81M Sell
114,834
-6,198
-5% -$458K 0.01% 1300
2024
Q2
$8.39M Sell
121,032
-11,103
-8% -$779K 0.01% 1267
2024
Q1
$9.37M Sell
132,135
-19,854
-13% -$1.38M 0.01% 1199
2023
Q4
$10.5M Sell
151,989
-26,255
-15% -$1.74M 0.01% 1072
2023
Q3
$11.6M Sell
178,244
-6,496
-4% -$436K 0.01% 958
2023
Q2
$12.5M Buy
184,740
+3,417
+2% +$236K 0.01% 938
2023
Q1
$12.3M Sell
181,323
-12,212
-6% -$804K 0.01% 914
2022
Q4
$12.3M Sell
193,535
-36,459
-16% -$2.23M 0.01% 883
2022
Q3
$13.1M Sell
229,994
-43,679
-16% -$2.74M 0.01% 816
2022
Q2
$17.3M Sell
273,673
-69,831
-20% -$4.69M 0.02% 686
2022
Q1
$24.8M Sell
343,504
-42,820
-11% -$3.11M 0.02% 599
2021
Q4
$29.7M Sell
386,324
-65,092
-14% -$4.96M 0.02% 564
2021
Q3
$34M Sell
451,416
-79,831
-15% -$6.2M 0.03% 484
2021
Q2
$40.1M Sell
531,247
-32,055
-6% -$2.42M 0.04% 421
2021
Q1
$41.1M Sell
563,302
-146,164
-21% -$10.7M 0.04% 373
2020
Q4
$52.1M Sell
709,466
-52,418
-7% -$3.69M 0.06% 278
2020
Q3
$51.9M Buy
761,884
+67,355
+10% +$4.59M 0.06% 251
2020
Q2
$45.9M Sell
694,529
-391,263
-36% -$25.4M 0.06% 258
2020
Q1
$67.4M Buy
1,085,792
+340,534
+46% +$23.9M 0.11% 162
2019
Q4
$55.6M Buy
745,258
+340,607
+84% +$25.4M 0.07% 247
2019
Q3
$29.7M Sell
404,651
-34,440
-8% -$2.49M 0.04% 397
2019
Q2
$31.9M Buy
439,091
+19,888
+5% +$1.43M 0.05% 382
2019
Q1
$30.2M Sell
419,203
-11,720
-3% -$821K 0.05% 376
2018
Q4
$28.7M Buy
430,923
+86,942
+25% +$5.97M 0.05% 332
2018
Q3
$25M Buy
343,981
+8,649
+3% +$624K 0.04% 451
2018
Q2
$23.9M Buy
335,332
+12,646
+4% +$930K 0.04% 433
2018
Q1
$23.8M Sell
322,686
-606
-0.2% -$44.7K 0.04% 411
2017
Q4
$23.6M Buy
323,292
+81,488
+34% +$5.87M 0.04% 405
2017
Q3
$17.2M Buy
241,804
+55,916
+30% +$3.94M 0.03% 507
2017
Q2
$12.9M Buy
185,888
+38,145
+26% +$2.63M 0.03% 598
2017
Q1
$9.75M Sell
147,743
-23,407
-14% -$1.5M 0.02% 685
2016
Q4
$10.5M Sell
171,150
-402,096
-70% -$25.4M 0.03% 614
2016
Q3
$38.8M Sell
573,246
-5,230
-0.9% -$352K 0.11% 196
2016
Q2
$38.4M Buy
578,476
+89,986
+18% +$6.02M 0.12% 184
2016
Q1
$32.5M Buy
488,490
+155,758
+47% +$9.91M 0.11% 200
2015
Q4
$21.6M Buy
332,732
+139,434
+72% +$9.09M 0.08% 288
2015
Q3
$12.1M Buy
193,298
+74,221
+62% +$4.83M 0.05% 415
2015
Q2
$7.78M Buy
+119,077
New +$8.08M 0.03% 613
2015
Q1
Sell
-86,066
Closed -$5.31M 2342
2014
Q4
$5.31M Buy
86,066
+128
+0.1% +$8.02K 0.03% 652
2014
Q3
$5.38M Buy
85,938
+849
+1% +$55K 0.03% 595
2014
Q2
$5.56M Buy
85,089
+24,538
+41% +$1.59M 0.03% 586
2014
Q1
$3.8M Buy
60,551
+4,752
+9% +$291K 0.03% 690
2013
Q4
$3.44M Buy
55,799
+8,913
+19% +$546K 0.03% 685
2013
Q3
$2.86M Buy
46,886
+7,757
+20% +$460K 0.02% 710
2013
Q2
$2.24M Buy
+39,129
New +$2.34M 0.02% 754

Other funds holding EFAV

Raymond James & Associates's EFAV Position: Q3 2024 in Review

Raymond James & Associates reduced its iShares MSCI EAFE Min Vol Factor ETF (EFAV) stake by 5.1% in Q3 2024, selling an estimated $458K and leaving 114,834 shares worth $8.81M. The position accounts for 0.01% of the portfolio, ranked #1300.

Raymond James & Associates first reported a position in EFAV in Q2 2013 and has held it in 45 quarters since. The position peaked at $67.4M in Q1 2020. 474 funds tracked by Wall St. Rank hold EFAV as of Q3 2024.

  • Raymond James & Associates held 114,834 shares of iShares MSCI EAFE Min Vol Factor ETF worth $8.81M as of Q3 2024.
  • Raymond James & Associates sold 6,198 iShares MSCI EAFE Min Vol Factor ETF shares in Q3 2024, an estimated $458K.
  • iShares MSCI EAFE Min Vol Factor ETF made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1300 holding.
  • Raymond James & Associates first reported a position in iShares MSCI EAFE Min Vol Factor ETF in Q2 2013 and has held it in 45 quarters since.
  • Raymond James & Associates's iShares MSCI EAFE Min Vol Factor ETF position peaked at $67.4M in Q1 2020.
  • 474 funds tracked by Wall St. Rank held iShares MSCI EAFE Min Vol Factor ETF as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.